Healthcare AI Platform Capabilities

The current Regenemm capability set is about governed clinical AI, documentation quality, secure sharing and workflow support.

Participate in Pilot Study
Regenemm® iOS app shown on an iPhone

Modern healthcare AI needs clinical governance

These pages now connect CTI's research lineage with Regenemm's current clinical AI infrastructure, trust, documentation and care coordination work.

From early wellbeing concepts to clinical systems

The original campaign focused on stress performance, biometric signals and psychometric feedback. The current work is broader: governed healthcare AI that supports clinicians, patients, documentation, coordination and audit-ready workflows.

The through-line remains careful human performance work, but the implementation standard is now healthcare-grade: clinical review, provenance, consent, privacy, security and measurable product quality.

Clinician-led product judgement
Trust, governance and interoperability by design
Professional healthcare team
Regenemm Healthcare workflow screens

Where this work now points

Use these refreshed pages as topical gateways into today's CTI and Regenemm work: clinical communication, secure AI documentation, patient clarity, consent-first sharing and responsible automation.

Capabilities that matter in clinical work

The feature story has shifted from wellness-app inputs to healthcare infrastructure: capturing context, drafting useful outputs, supporting review, preserving provenance and moving information safely.

Clinical capture

Useful systems preserve consultation context and source material so downstream outputs are grounded.

Draft generation

AI can assist with notes, letters, summaries and education material when the workflow expects human review.

Review and approval

Clinician approval status should be visible before outputs are shared or relied upon.

Provenance

Every generated document should retain a path back to source context, review events and final sign-off.

Secure sharing

Clinical information should move through consent-aware, role-aware and auditable pathways.

Evaluation

Product quality needs regression checks, safety review and measurable workflow performance, not anecdotal demos.